Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative
- 1 October 1998
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 132 (1-2) , 45-50
- https://doi.org/10.1016/s0304-3835(98)00156-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Diagnosis and reversal of multidrug resistance in paediatric cancersEuropean Journal Of Cancer, 1996
- Clinical multidrug resistance in cancer: A multifactorial problemEuropean Journal Of Cancer, 1996
- Clinical trials of p-glycoprotein reversal in solid tumoursEuropean Journal Of Cancer, 1996
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicinBritish Journal of Cancer, 1995
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Restoration of Taxol Sensitivity of Multidrug-Resistant Cells by the Cyclosporine SDZ PSC 833 and the Cyclopeptolide SDZ 280-446JNCI Journal of the National Cancer Institute, 1993
- SDZ PSC 833, A non‐immunosuppressive cyclosporine: Its potency in overcoming P‐glycoprotein‐mediated multidrug resistance of murine leukemiaInternational Journal of Cancer, 1992
- Photoaffinity substrates for P-glycoproteinBiochemical Pharmacology, 1992
- Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicinBritish Journal of Cancer, 1986